DK1369115T3 - Fremgangsmåder til forebyggelse af brystcancer ved administration af raloxifen - Google Patents

Fremgangsmåder til forebyggelse af brystcancer ved administration af raloxifen

Info

Publication number
DK1369115T3
DK1369115T3 DK03102726T DK03102726T DK1369115T3 DK 1369115 T3 DK1369115 T3 DK 1369115T3 DK 03102726 T DK03102726 T DK 03102726T DK 03102726 T DK03102726 T DK 03102726T DK 1369115 T3 DK1369115 T3 DK 1369115T3
Authority
DK
Denmark
Prior art keywords
methods
breast cancer
cancer prevention
raloxifene
administering
Prior art date
Application number
DK03102726T
Other languages
Danish (da)
English (en)
Inventor
Fredric Jay Cohen
Ronald Keith Knickerbocker
Nikolaus Thomas Nickelsen
Teri Janine Scott
Joan Ellen Glusman
Robert Stephen Eckert
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27268608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1369115(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9624800.0A external-priority patent/GB9624800D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1369115T3 publication Critical patent/DK1369115T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DK03102726T 1996-10-30 1997-10-29 Fremgangsmåder til forebyggelse af brystcancer ved administration af raloxifen DK1369115T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2985096P 1996-10-30 1996-10-30
GBGB9624800.0A GB9624800D0 (en) 1996-11-29 1996-11-29 Methods of preventing breast cancer
US4026097P 1997-03-10 1997-03-10

Publications (1)

Publication Number Publication Date
DK1369115T3 true DK1369115T3 (da) 2007-01-02

Family

ID=27268608

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97308588T DK0839532T3 (da) 1996-10-30 1997-10-29 Forbedringer af eller i forbindelse med forebyggelse af brystkræft ved indgift af raloxifen
DK03102726T DK1369115T3 (da) 1996-10-30 1997-10-29 Fremgangsmåder til forebyggelse af brystcancer ved administration af raloxifen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK97308588T DK0839532T3 (da) 1996-10-30 1997-10-29 Forbedringer af eller i forbindelse med forebyggelse af brystkræft ved indgift af raloxifen

Country Status (44)

Country Link
US (2) US6303634B1 (no)
EP (3) EP0839533A1 (no)
JP (2) JPH10147529A (no)
CN (2) CN1182591A (no)
AP (1) AP971A (no)
AR (2) AR010538A1 (no)
AT (2) ATE338551T1 (no)
AU (3) AU5005197A (no)
BE (2) BE1011382A5 (no)
BG (1) BG63841B1 (no)
BR (1) BR9712703A (no)
CA (2) CA2219377A1 (no)
CH (2) CH691847A5 (no)
CZ (2) CZ300261B6 (no)
DE (2) DE69721692T2 (no)
DK (2) DK0839532T3 (no)
EA (2) EA002054B1 (no)
EE (1) EE03663B1 (no)
ES (4) ES2135342B1 (no)
FR (2) FR2755014B1 (no)
GB (3) GB2318734B (no)
GE (1) GEP20032910B (no)
GR (2) GR970100409A (no)
HK (1) HK1010495A1 (no)
HU (2) HUP9701777A3 (no)
IE (2) IE970772A1 (no)
IL (2) IL122026A0 (no)
IS (1) IS5035A (no)
IT (2) IT1298470B1 (no)
LU (2) LU90157B1 (no)
LV (1) LV12353B (no)
MY (1) MY121623A (no)
NL (2) NL1007387C2 (no)
NO (2) NO974973D0 (no)
NZ (1) NZ329042A (no)
PT (2) PT839532E (no)
RO (1) RO120813B1 (no)
SG (2) SG72765A1 (no)
SI (3) SI0839532T1 (no)
SK (1) SK287047B6 (no)
TR (1) TR199900951T2 (no)
UA (1) UA46762C2 (no)
WO (2) WO1998018449A1 (no)
YU (1) YU42397A (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
GB9624800D0 (en) * 1996-11-29 1997-01-15 Lilly Co Eli Methods of preventing breast cancer
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
FI982733A (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
DE60202954T2 (de) 2001-05-22 2006-01-05 Eli Lilly And Co., Indianapolis Tetrahydrochinolin-derivate zur behandlung von krankheiten ausgelöst durch zu hohem oder zu niedrigem oestrogenspiegel
ATE321754T1 (de) 2001-05-22 2006-04-15 Lilly Co Eli 2-substituierte 1,2,3,4-tetrahydrochinoline und derivate davon, zusammensetzungen und verfahren
US20040225200A1 (en) * 2003-05-09 2004-11-11 Edmundson Catherine M. System and method of analyzing the health of a population
GR1005694B (el) * 2005-06-08 2007-10-22 Αλεξης Μιχαηλ Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
CN102973573B (zh) * 2012-11-28 2015-04-08 玉林师范学院 一种人乳腺癌细胞抑制剂及制备方法
CN103830197A (zh) * 2014-03-14 2014-06-04 崔书豪 一种盐酸雷洛昔芬分散片及其制备方法
CN116650484A (zh) * 2023-05-11 2023-08-29 南通大学 一种乳腺癌相关蛋白的抑制剂及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4656187A (en) * 1981-08-03 1987-04-07 Eli Lilly And Company Treatment of mammary cancer
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
EP0652004B1 (en) * 1993-10-15 2002-07-10 Eli Lilly And Company Methods for treating resistant neoplasms
US5478847A (en) * 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
ZA951497B (en) * 1994-03-02 1996-08-23 Lilly Co Eli Orally administerable pharmaceutical formulations
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5521214A (en) * 1995-01-25 1996-05-28 Eli Lilly And Company Methods of inhibiting environmental estrogens
US5821254A (en) 1995-02-17 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
CZ300341B6 (cs) * 1996-03-26 2009-04-22 Eli Lilly And Company Farmaceutická kompozice obsahující raloxifen

Also Published As

Publication number Publication date
SK287047B6 (sk) 2009-10-07
EA006083B1 (ru) 2005-08-25
HUP9701778A2 (hu) 1999-01-28
BG103369A (en) 2000-05-31
AU731388B2 (en) 2001-03-29
CA2219377A1 (en) 1998-04-30
IT1298470B1 (it) 2000-01-10
BE1011382A5 (fr) 1999-08-03
ES2135343A1 (es) 1999-10-16
US6303634B1 (en) 2001-10-16
US20020019418A1 (en) 2002-02-14
LV12353A (lv) 1999-10-20
IE970773A1 (en) 2000-02-09
EA002054B1 (ru) 2001-12-24
CH691847A5 (fr) 2001-11-15
CZ341297A3 (cs) 1998-05-13
LU90157B1 (fr) 1998-06-02
GB9722801D0 (en) 1997-12-24
DE69736644D1 (de) 2006-10-19
FR2755014A1 (fr) 1998-04-30
EP0839532A1 (en) 1998-05-06
CZ341197A3 (cs) 1998-05-13
MY121623A (en) 2006-02-28
PT1369115E (pt) 2006-12-29
CN1182590A (zh) 1998-05-27
ATE239475T1 (de) 2003-05-15
IS5035A (is) 1999-04-27
DE69721692T2 (de) 2004-03-25
GB9722796D0 (en) 1997-12-24
CZ300261B6 (cs) 2009-04-01
CA2219070C (en) 2007-12-18
FR2756490B1 (fr) 2003-06-20
SK55999A3 (en) 2000-06-12
HU9701777D0 (en) 1997-12-29
HU9701778D0 (en) 1997-12-29
ES2197312T3 (es) 2004-01-01
SI1369115T1 (sl) 2006-12-31
ES2135342B1 (es) 2000-05-16
TR199900951T2 (xx) 1999-07-21
AU5005697A (en) 1998-05-22
AR013864A1 (es) 2001-01-31
JPH10147529A (ja) 1998-06-02
EP0839532B1 (en) 2003-05-07
AP971A (en) 2001-05-30
GB2318734A (en) 1998-05-06
NZ329042A (en) 1999-08-30
EP1369115A1 (en) 2003-12-10
SI0839532T1 (en) 2003-10-31
HUP9701777A3 (en) 1999-07-28
ATE338551T1 (de) 2006-09-15
EA200100716A1 (ru) 2002-06-27
IL122025A0 (en) 1998-03-10
NO974973D0 (no) 1997-10-28
NL1007387C2 (nl) 1998-05-14
PT839532E (pt) 2003-09-30
WO1998018325A1 (en) 1998-05-07
GB2318734B (en) 1999-12-01
SG83672A1 (en) 2001-10-16
NO974972L (no) 1998-05-04
GEP20032910B (en) 2003-03-25
IL122026A0 (en) 1998-03-10
NL1007386C2 (nl) 1998-05-14
RO120813B1 (ro) 2006-08-30
DK0839532T3 (da) 2003-08-25
LU90158B1 (fr) 1998-06-02
MX9708340A (es) 1998-08-30
AU4364897A (en) 1998-05-07
AU4364797A (en) 1998-05-07
HUP9701777A2 (hu) 1999-06-28
SI20107A (sl) 2000-06-30
IE970772A1 (en) 2000-02-09
NO322468B1 (no) 2006-10-09
CN1182591A (zh) 1998-05-27
FR2755014B1 (fr) 1999-02-05
EP0839533A1 (en) 1998-05-06
IL122025A (en) 2003-01-12
DE69736644T2 (de) 2007-10-25
AP9901494A0 (en) 1999-03-31
HUP9701778A3 (en) 1999-06-28
ES2271476T3 (es) 2007-04-16
JPH10147530A (ja) 1998-06-02
ITMI972433A1 (it) 1999-04-29
WO1998018449A1 (en) 1998-05-07
ITMI972434A1 (it) 1999-04-29
GR1003189B (el) 1999-09-01
HK1010495A1 (en) 1999-06-25
GB9911557D0 (en) 1999-07-21
EE03663B1 (et) 2002-04-15
MX9708341A (es) 1998-08-30
CH693820A5 (fr) 2004-02-27
EA199900431A1 (ru) 1999-10-28
SG72765A1 (en) 2000-05-23
AR010538A1 (es) 2000-06-28
DE69721692D1 (de) 2003-06-12
GB2318733A (en) 1998-05-06
ES2135342A1 (es) 1999-10-16
NO974972D0 (no) 1997-10-28
YU42397A (sh) 2000-10-30
GR970100408A (el) 1998-06-30
GR970100409A (el) 1998-06-30
EE9900162A (et) 1999-12-15
FR2756490A1 (fr) 1998-06-05
UA46762C2 (uk) 2002-06-17
CA2219070A1 (en) 1998-04-30
BE1011381A5 (fr) 1999-08-03
LV12353B (en) 2000-02-20
EP1369115B1 (en) 2006-09-06
BG63841B1 (bg) 2003-03-31
AU5005197A (en) 1998-05-22
BR9712703A (pt) 1999-10-26

Similar Documents

Publication Publication Date Title
DK1369115T3 (da) Fremgangsmåder til forebyggelse af brystcancer ved administration af raloxifen
IS4886A (is) Skömmtunarbúnaður fyrir einingarskammta
EE03656B1 (et) Raadiotelefoni elektromagnetiline varje
DE69834019D1 (de) Dose
NO20010556L (no) Fremgangsmate for oftalmisk administrering
IT248598Y1 (it) Scudo per la protezione dorsale.
DK1100474T3 (da) Todelt kapsel til optag af farmaceutiske tilberedninger til inhalatorer
ID19886A (id) Terapi gabungan untuk osteoporosis
NO975973D0 (no) Anordning ved utblåsningssikring
EP0938901A4 (en) MEDICINAL COMPOSITIONS FOR TREATING HEPATIC CONDITIONS
NO983090D0 (no) Terapeutiske forbindelser
DE69727569D1 (de) Chrysanthellum indicum extrakt enthaltendes, kosmetisches schlankheitsmittel
IDP000008233A (id) Metode pencegahan kanker payudara
DE29817592U1 (de) Dose
FI970717A0 (fi) Menetelmät kohtusyövän inhiboimiseksi
DE29615762U1 (de) Mietfachanordnung
NO963375D0 (no) Anordning ved gravemaskinskuff
NO943565D0 (no) Prepareringsmaskin for skilöype
SE9001466D0 (sv) Stoeldskydd, saerskilt foer skor
KR980003051U (ko) 수맥 차단용 장판
NO965332D0 (no) Terapeutisk perparat
SE9400370D0 (sv) Therapeutic preparation for inhalation
SE9502576D0 (sv) Therapeutic preparations for inhalation II
KR970062552U (ko) 공사용 안전 칸막이
KR970062553U (ko) 공사용 안전 칸막이